Tekmira/OnCore

(SEDAR filing: 4 February 2015) Management information circular of Tekmira Pharmaceuticals Corporation ("Tekmira") for the merger of its wholly-owned subsidiary, TKM Acquisition Corporation ("Merger Sub") into OnCore Biopharma, Inc. ("OnCore") (1913 K). Farris,Vaughan/Dorsey & Whitney (U.S.)
Summaries
Summary Under
Tax Topics - Public Transactions - Mergers & Acquisitions - Cross-Border Acquisitions - Outbound - Delaware etc. Mergers
OnCore merger into Delaware subsidiary of Tekmira Pharmaceuticals
Overview

OnCore, a private Delaware company with a controlling Bermuda sharehholder, will be merged into a Delaware subsidiary of Tekmira, a BC...

The text of this content is paywalled except for the first five days of each month. Subscribe or log in for unrestricted access.